Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15709190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia

  2004cited by this paper
• Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

  2004cited by this paper
• Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

  2004cited by this paper
• Methylation changes in faecal DNA: a marker for colorectal cancer screening?

  2004cited by this paper
• DNA Methylation Markers in Patients with Gastrointestinal Cancers

  2004cited by this paper
• The relationship between hypomethylation and CpG island methylation in colorectal neoplasia.

  2003cited by this paper
• SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

  2003cited by this paper
• Early detection: The power and the promise of DNA methylation markers

  2003cited by this paper
• Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas.

  2003cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53.

  2003cited by this paper
• Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.

  2002cited by this paper
• Concordant CpG island methylation in hyperplastic polyposis.

  2002cited by this paper
• HLTF gene silencing in human colon cancer

  2002cited by this paper
• Genetic and epigenetic alterations in colon cancer.

  2002cited by this paper
• CpG island methylation in aberrant crypt foci of the colorectum.

  2002cited by this paper
• Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

  2002cited by this paper
• Evolution of colorectal cancer: Change of pace and change of direction

  2002cited by this paper
• Detection of APC mutations in fecal DNA from patients with colorectal tumors.

  2002cited by this paper
• CpG island methylation in colorectal adenomas.

  2001cited by this paper
• Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.

  2001cited by this paper
• Detecting colorectal cancer in stool with the use of multiple genetic targets.

  2001cited by this paper
• Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer.

  2001cited by this paper
• Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes.

  2000cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

  2000cited by this paper
• Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.

  1999cited by this paper
• Aging and DNA methylation in colorectal mucosa and cancer.

  1998cited by this paper
• Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

  1998cited by this paper
• Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• Prospective study of the frequency and size distribution of polyps missed by colonoscopy.

  1990cited by this paper
• Cell culture of human colon adenomas and carcinomas.

  1987cited by this paper

• Hierarchical clustering defines hypermethylated RSPO2 as early-stage potential biomarker in colorectal cancer

  2025cites this paper
• Construction of a target-stimulated nanoparticle-assembly homogeneous sensing platform for multiplexed DNA methylation assay

  2025cites this paper
• MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas

  2025cites this paper
• Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration

  2024cites this paper
• A review on trends in development and translation of omics signatures in cancer

  2024cites this paper
• Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment

  2024cites this paper
• Functional characterization of age-dependent p16 epimutation reveals biological drivers and therapeutic targets for colorectal cancer

  2023cites this paper
• Colon Cancer Screening Methods: 2023 Update

  2023influential citation
• Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer

  2023cites this paper
• The Role of Glucosamine and Chondroitin Sulfate in the Prevention of Colorectal Cancer: A Systematic Review

  2022cites this paper
• Significance of ZEB2 in the immune microenvironment of colon cancer

  2022cites this paper
• Novel Diagnostic Biomarkers in Colorectal Cancer

  2022cites this paper
• DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine

  2022cites this paper
• Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

  2022cites this paper
• Genome-wide analysis of DNA methylation identi es the apoptosis-related gene UQCRH in renal cancer

  2021cites this paper
• A New Method for the Detection of Colorectal Cancer and the Precancerous Lesions: Occult Blood Testing Combination with Promoter Methylation in the Fecal Sample

  2021cites this paper
• Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.

  2021cites this paper
• Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta‐analysis

  2021cites this paper
• Genome‐wide analysis of DNA methylation identifies the apoptosis‐related gene UQCRH as a tumor suppressor in renal cancer

  2021cites this paper
• Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.

  2020cites this paper
• Molecular basis of diseases of the gastrointestinal tract

  2020cites this paper
• Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation

  2020cites this paper
• A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.

  2019cites this paper
• [Epigenetic research progress in colorectal cancer].

  2019cites this paper
• Genome‐wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine‐phosphate‐guanine methylation and histological subtypes

  2019cites this paper
• Adjuvant and Neoadjuvant Therapy for Colorectal Cancer

  2019cites this paper
• [Role and alterations of DNA methylation during the aging and cancer].

  2018cites this paper
• DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

  2018cites this paper
• The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis

  2018cites this paper
• DNA methylation patterns as molecular biomarkers: an overview in colorectal cancer

  2018cites this paper
• Procaine is a specific DNA methylation inhibitor with anti‐tumor effect for human gastric cancer

  2018cites this paper
• Colorectal cancer: epigenetic alterations and their clinical implications.

  2017cites this paper
• Vitamin D and Colorectal Carcinogenesis

  2017cites this paper
• DNA and Histone Methylation in Colon Cancer

  2017cites this paper
• The Conundrum of Genetic “Drivers” in Benign Conditions

  2016cites this paper
• DNA methylation markers for early detection of colorectal cancer : clinical applicability and biological function

  2016cites this paper
• The pleiotropic effects of vitamin D promoting bowel health

  2016cites this paper
• Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker.

  2016cites this paper
• Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.

  2016cites this paper
• Molecular characteristics of colorectal serrated polyps and hyperplastic polyps

  2016cites this paper
• Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer

  2016cites this paper
• Comparative detection of aberrantly methylated DNA in preoperative and postoperative stool from patients with colorectal cancers

  2015influential citation
• Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.

  2015cites this paper
• Epigenetics Territory and Cancer

  2015cites this paper
• Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer

  2015influential citation
• Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer

  2015cites this paper
• Characterizing the Hypermutated Subtype of Advanced Prostate Cancer as a Predictive Biomarker for Precision Medicine

  2015cites this paper
• Methylation in Colorectal Cancer

  2015cites this paper
• IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer

  2014cites this paper
• Advances in epigenetic biomarker research in colorectal cancer.

  2014cites this paper
• DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

  2014cites this paper
• DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA

  2014cites this paper
• Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

  2014cites this paper
• p33ING1b methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions

  2014cites this paper
• Molecular Markers of Carcinogenesis for Risk Stratification of Individuals with Colorectal Polyps: A Case–Control Study

  2014cites this paper
• Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients

  2014cites this paper
• CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas

  2014cites this paper
• " Parkland-ut Southwestern Prospr Center: Colon Cancer Screening in a Safety Net. " (celette

  2014cites this paper
• RSPO2–LGR5 signaling has tumour-suppressive activity in colorectal cancer

  2014cites this paper
• Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.

  2014cites this paper
• Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study

  2013cites this paper
• Accuracy of early detection of colorectal tumours by stool methylation markers: A meta-analysis

  2013cites this paper
• Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention

  2013influential citation
• Human Cancer Epigenetics

  2013cites this paper
• Molecular Pathology of Inflammatory Bowel Disease-Associated Neoplasia

  2013cites this paper
• Molecular patterns in the evolution of serrated lesion of the colorectum

  2013cites this paper
• Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study.

  2013cites this paper
• Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

  2013cites this paper
• DNA Methylation Biomarkers of Stool and Blood for Early Detection of Colon Cancer

  2013cites this paper
• Chapter 2 Molecular screening to colorectal cancer Adapted from : Molecular tests for colorectal cancer screening

  2013cites this paper
• Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection

  2012cites this paper
• Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation

  2012cites this paper
• Promoter CpG island methylation markers in colorectal cancer: the road ahead.

  2012cites this paper
• Stool DNA Testing for Colorectal Cancer: Development and Advances

  2012cites this paper
• Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma

  2012cites this paper
• Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma

  2012cites this paper
• Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.

  2012cites this paper
• Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon–rectum

  2012cites this paper
• Epigenetic Biomarkers in Cancer Detection and Diagnosis

  2012cites this paper
• From Bench to Bed : Molecular Markers for Clinical Use

  2012cites this paper
• DNA methylation testing and marker validation using PCR: diagnostic applications

  2012cites this paper
• Genetic and Epigenetic Biomarkers in Cancer

  2012cites this paper
• Early Detection of Colon Cancer

  2012cites this paper
• Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract

  2011cites this paper
• Fecal Molecular Markers for Colorectal Cancer Screening

  2011cites this paper
• Sporadic colorectal polyps and mismatch repair proteins.

  2011cites this paper
• Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta‐analysis

  2011cites this paper
• Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer Identifies Genes Commonly Affected by Epigenetic Alterations

  2011cites this paper
• Predictive and Prognostic Factors in Colorectal Cancer: A Personalized Approach

  2011cites this paper
• Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer

  2011cites this paper
• 9 – Stool and Blood Sampling for Early Detection of Colorectal Cancer

  2011cites this paper
• Molecular tests for colorectal cancer screening.

  2011cites this paper
• Novel methylation panel for the early detection of colorectal tumors in stool DNA.

  2010cites this paper
• Practical advances in stool screening for colorectal cancer.

  2010cites this paper
• Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.

  2010cites this paper
• DNA methylation markers in colorectal cancer

  2010influential citation
• Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer.

  2010cites this paper
• Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression

  2010cites this paper
• Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.

  2010cites this paper
• Performance improvements of stool-based screening tests.

  2010cites this paper